Full Text of SR0019 103rd General Assembly
SR0019 103RD GENERAL ASSEMBLY |
| | SR0019 | | LRB103 25946 ECR 52298 r |
|
| 1 | | SENATE RESOLUTION
| 2 | | WHEREAS, Pancreatic cancer is the third leading cause of | 3 | | cancer-related deaths in the U.S. and is projected to be the | 4 | | second leading cause of cancer-related deaths by 2030; and
| 5 | | WHEREAS, Pancreatic cancer is one of the deadliest cancers | 6 | | and has the lowest five-year survival rate at just 10%; and
| 7 | | WHEREAS, In 2023, an estimated 60,430 U.S. residents will | 8 | | be diagnosed with pancreatic cancer, and more than 48,220 will | 9 | | die from the disease; and
| 10 | | WHEREAS, Due to increased awareness, pancreatic cancer | 11 | | survival rates have been improving; however, the disease is | 12 | | still considered largely incurable; with all stages of | 13 | | pancreatic cancer combined, the one-year relative survival | 14 | | rate is 20% and the five-year rate is 9%; and
| 15 | | WHEREAS, The problem is that high-risk people are not | 16 | | being screened in the early and potentially curable stages of | 17 | | pancreatic cancer; and
| 18 | | WHEREAS, Risk factors can include chronic or hereditary | 19 | | pancreatitis, obesity, regular consumption of high dietary | 20 | | fats, alcohol abuse, smoking, family history, age, and |
| | | SR0019 | - 2 - | LRB103 25946 ECR 52298 r |
|
| 1 | | long-standing diabetes; and
| 2 | | WHEREAS, Symptoms can include abdominal pain, mid-to-upper | 3 | | back pain, weight loss, jaundice that is yellowing of the skin | 4 | | and eyes, nausea, loss of appetite, changes in stool, and | 5 | | new-onset diabetes; and
| 6 | | WHEREAS, Early screening will save lives; therefore, be it
| 7 | | RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL | 8 | | ASSEMBLY OF THE STATE OF ILLINOIS, that we declare the month of | 9 | | November 2023 as Pancreatic Cancer Awareness Month in the | 10 | | State of Illinois; and be it further
| 11 | | RESOLVED, That suitable copies of this resolution be | 12 | | presented to the Pancreatic Cancer Action Network (PanCAN), | 13 | | the American Cancer Society, and Dr. Paul Grippo of the | 14 | | University of Illinois at Chicago with our sincere | 15 | | appreciation for their efforts to address pancreatic cancer.
|
|